IPSC

Century Therapeutics Stock Analysis

AI Rating

Great
  • Quality5/10
  • Growth↑ 8/10
  • Momentum↑ 9/10
Century Therapeutics sales and earnings growth
IPSC Growth
Good
  • Revenue Y/Y↑ 4121.12%
  • EPS Y/Y↑ 82.70%
  • FCF Y/Y↓ -0.07%
Century Therapeutics gross and profit margin trends
IPSC Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -23.40%
  • ROIC↓ -11.90%
Century Therapeutics net debt vs free cash flow
IPSC Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Century Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗